Template:Trichomonas antibiotics: Difference between revisions

 
(13 intermediate revisions by 8 users not shown)
Line 1: Line 1:
====Non-Pregnant====
====Non-Pregnant====
*[[Metronidazole]] 2g PO once or 500mg PO BID for 7 days
*[[Metronidazole]] 500mg PO BID for 7 days <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon</ref>
*[[Tinidazole]] 2g PO once
*[[Tinidazole]] 2g PO once
====Pregnant====
====Pregnant====
*Only treat if the patient is symptomatic and avoid breast feeding until 24hrs after last Metronidazole treatment and 72hrs after Tinidazole
''Only treat if the patient is symptomatic''
*[[Metronidazole]] 2g PO once
*[[Metronidazole]] 500mg PO BID for 7 days <ref>CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm</ref>


====Sexual Partner Treatment====
====Sexual Partner Treatment====
*[[Metronidazole]] 500mg PO BID x 7 days or [[Tinidazole]] 2g PO once
*Female: Same as above
 
*Male: [[Metronidazole]] 2 gm PO x1 <ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon </ref>
 
====Women with HIV Infection====
*Metronidazole 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref>

Latest revision as of 03:03, 26 December 2024

Non-Pregnant

Pregnant

Only treat if the patient is symptomatic

Sexual Partner Treatment

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  2. CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
  3. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon